Cargando…
SELENBP1 inhibits progression of colorectal cancer by suppressing epithelial–mesenchymal transition
Selenium-binding protein 1 (SELENBP1) is frequently dysregulated in various malignancies including colorectal cancer (CRC); however, its roles in progression of CRCs and the underlying mechanism remain to be elucidated. In this study, we compared the expression of SELENBP1 between CRCs and colorecta...
Autores principales: | Zhang, Xiaotian, Hong, Runqi, Bei, Lanxin, Hu, Zhiqing, Yang, Ximin, Song, Tao, Chen, Liang, Meng, He, Niu, Gengming, Ke, Chongwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438969/ https://www.ncbi.nlm.nih.gov/pubmed/36117772 http://dx.doi.org/10.1515/med-2022-0532 |
Ejemplares similares
-
GABRD promotes progression and predicts poor prognosis in colorectal cancer
por: Niu, Gengming, et al.
Publicado: (2020) -
Selenium binding protein 1 inhibits tumor angiogenesis in colorectal cancers by blocking the Delta-like ligand 4/Notch1 signaling pathway
por: Zhang, Xiaotian, et al.
Publicado: (2022) -
GJA1 promotes hepatocellular carcinoma progression by mediating TGF-β-induced activation and the epithelial–mesenchymal transition of hepatic stellate cells
por: Niu, Gengming, et al.
Publicado: (2021) -
Clinical study on risk factors related to postoperative recurrence or metastasis of rectal cancer: a retrospective cohort study
por: Wang, Huipeng, et al.
Publicado: (2022) -
PRELP has prognostic value and regulates cell proliferation and migration in hepatocellular carcinoma
por: Hong, Runqi, et al.
Publicado: (2020)